Efficacy of dose-reduced lenalidomide in patients with refractory or recurrent multiple myeloma

Purpose: Introduction of lenalidomide has expanded the therapeutic options for refractory and recurrent multiple myeloma (MM) patients. However, the application of the approved doses may be difficult in some patients due to adverse effects. Experimental design: Therefore, we evaluated the efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwamborn, Katharina, Gorschlüter, Marcus, Glasmacher, Axel, Schmidt-Wolf, Ingo G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3183805/
https://www.ncbi.nlm.nih.gov/pubmed/21966287
http://dx.doi.org/10.3205/000149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3183805/
https://www.ncbi.nlm.nih.gov/pubmed/21966287
http://dx.doi.org/10.3205/000149

Ejemplares similares